Amylin Pharmaceuticals, Inc. Registration Rights AgreementRegistration Rights Agreement • May 10th, 2004 • Amylin Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMay 10th, 2004 Company Industry JurisdictionAmylin Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the Purchasers (as defined herein) upon the terms set forth in the Purchase Agreement (as defined herein) its 2.50% Convertible Senior Notes due 2011 (the “Securities”). As an inducement to the Purchasers to enter into the Purchase Agreement and in satisfaction of a condition to the obligations of the Purchasers thereunder, the Company agrees with the Purchasers for the benefit of Holders (as defined herein) from time to time of the Registrable Securities (as defined herein) as follows: